The modified nanoparticles, in combination with an immune checkpoint blocker and hyperthermia, resulted in increased levels of inflammatory cytokines, mobilization of CD8 + T cells within the tumor, and suppression of primary and secondary tumors in a breast cancer model [92]. Here, CD8A is linked to neoplasm.